Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 Rapid Antigen Test”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableEnded earlyNCT04805840
What this trial is testing

Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen

Who this might be right for
Covid19
Columbia University 93
Not applicableWithdrawnNCT04808921
What this trial is testing

Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test

Who this might be right for
SARS-CoV-2Covid-19Coronavirus
Sky Medical Supplies & Equipments, LLC
Not applicableStudy completedNCT05074017
What this trial is testing

COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests

Who this might be right for
COVID-19SARS-CoV2 InfectionSARS (Disease)
Synlab Holding Deutschland GmbH 2,222
Not applicableStudy completedNCT04839094
What this trial is testing

Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19.

Who this might be right for
SARS-CoV-2
Centre Hospitalier Universitaire Vaudois 58
Not applicableUnknownNCT04878068
What this trial is testing

Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2

Who this might be right for
Covid19
Cannabis Research Associates 300
Not applicableUnknownNCT04403906
What this trial is testing

Somerset and South Essex Coronavirus Antigen Testing

Who this might be right for
COVIDSARS-CoV 2
Somerset NHS Foundation Trust 200
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableStudy completedNCT05047900
What this trial is testing

The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community

Who this might be right for
Covid19SARS-CoV-2Community Transmissions+1 more
Mahidol University 70,000
Not applicableStudy completedNCT05911074
What this trial is testing

COVID-19 Antigen Rapid Test Evaluation in Low-Prevalence Setting

Who this might be right for
Corona Virus Infection
Foundation for Innovative New Diagnostics, Switzerland 7,274
Not applicableStudy completedNCT04750629
What this trial is testing

Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)

Who this might be right for
SARS-CoV-2Covid19
Lumos Diagnostics 140
Not applicableWithdrawnNCT04898127
What this trial is testing

Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.

Who this might be right for
Covid19
Norwegian Institute of Public Health
Not applicableStudy completedNCT05498727
What this trial is testing

Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya

Who this might be right for
COVID-19
Elizabeth Glaser Pediatric AIDS Foundation 527,184
Post-approval studies (Phase 4)Study completedNCT06065176
What this trial is testing

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Who this might be right for
COVID-19Vaccine-Preventable DiseasesSARS CoV 2 Infection+2 more
Sarang K. Yoon, DO, MOH 1,188
Large-scale testing (Phase 3)Study completedNCT05459532
What this trial is testing

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

Who this might be right for
COVID-19
University of Witwatersrand, South Africa 59
Not applicableStudy completedNCT04689399
What this trial is testing

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

Who this might be right for
Covid19Rapid Antigen TestSARS-CoV-2
Rigshospitalet, Denmark 4,697
Not applicableEnded earlyNCT05403346
What this trial is testing

Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)

Who this might be right for
SARS-CoV-2Covid19
Lumos Diagnostics 45
Not applicableEnded earlyNCT05618561
What this trial is testing

EuGeni Rapid Antigen Test for the Qualitative Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Causing COVID19 Disease in Compliance With the World Health Organization (WHO)

Who this might be right for
SARS-CoV-2 Infection
AnteoTech Ltd 599
Not applicableStudy completedNCT05045846
What this trial is testing

Diagnostic Accuracy of Rapid Antigen Test Based on Anterior Nasal Swab Compared With RT-PCR for SARS-CoV-2 Detection.

Who this might be right for
Covid19
Christian von Buchwald 3,461
Not applicableUnknownNCT05161299
What this trial is testing

CovidSurg-3: Outcomes of Surgery in COVID-19 Infection

Who this might be right for
SARS-CoV-2 InfectionSurgery
University of Birmingham 2,000
Not applicableStudy completedNCT05529771
What this trial is testing

Clinical Outcomes of paTients pREsenting to HArare COVID-19 CenTer of Excellence With SARS-CoV-2 Infection

Who this might be right for
COVID-19
Elizabeth Glaser Pediatric AIDS Foundation 266
Load More Results